[Author: Paul S. Jensen, O.D. ] In the last decade, tremendous advances have been made in understanding dry eye disease. Landmark collaborations such as the Dry Eye Workshop and their reports have changed practice guidelines and improved patient care. One type of dry eye might require more attention, though. Among the … [Read more...]
New Allergan survey shows 48% have dry eye symptoms
April 18, 2012 By Leave a Comment
News from the American Optometric Association: Dry eye has long been recognized as a common and often chronic problem, particularly in older adults. However, the recently released Allergan Dry Eye Survey, conducted by Harris Interactive, suggests the condition may be even more prevalent than previously believed. The survey … [Read more...]
New ‘BAK-free’ treatment for OSD in glaucoma patients
April 17, 2012 By 1 Comment
Ocular Surface Disease in glaucoma patients can be a significant issue in treatment non-compliance as well as patient Quality of Life. Preservatives such as BAK (bensalkonium chloride) have long been know to cause adverse effects to the cornea. Colin Chan, MD and Michael Kook, MD discussed recently the opportunity for using new … [Read more...]
Post cataract surgery dry eye – an ‘unmet need’
April 17, 2012 By Leave a Comment
Post cataract surgery dry eye- an 'unmet need' report from ASCRS EyeWorld meeting reporter highlighted comments by Victor Caparas, MD who stated cataract surgeons cannot ignore the effects of surgery on the ocular surface. Dr Caparas reminded doctors that the pre-corneal tear film is the surface with the largest optical power; … [Read more...]
Clinical Utility of Objective Tests for Dry Eye Disease: Variability Over Time and Implications for Clinical Trials and Disease Management.
April 12, 2012 By Leave a Comment
In a recent pre-publication release in the "Cornea" journal, tear osmolarity showed both treatment response and evidence of lower variability compared with other commonly used signs of Dry Eye Disease (DED). The study included DED patients being treated over a 3 month period utilizing topical cyclosporine 0.05% (Restasis). By … [Read more...]
New insights advance diagnosis, treatment of inflammatory dry eye
April 12, 2012 By Leave a Comment
This article in OSN provides leading experts input on the importance of diagnosing and managing Dry Eye Disease (DED) which can lead to poor surgical outcomes as well as complications. It also discusses the role of inflammatory cascades and tear osmolarity and their role in both evaporative and aqueous-deficient DED. Several … [Read more...]
Don’t ignore the Ocular Surface in your Premium IOL Patients
April 9, 2012 By Leave a Comment
Summary: In Ocular Surgery News, Mitch Jackson, MD reports that " managing patient expectations, conducting the preoperative evaluation and addressing cystoid macular edema are all critical aspects in making the premium IOL patient happy and ensuring a premium outcome. However, ignoring the ocular surface, one of the remaining … [Read more...]
Distinguishing Evaporative from Aqueous Deficient Dry Eye
April 9, 2012 By Leave a Comment
Authors: Michael A. Lemp, MD, FACS, and Gerd Geerling, MD, PHD From the article: The accurate diagnosis of dry eye syndrome (DES), along with classification of its severity and subtype, is essential to developing an effective treatment plan. DES is diagnosed more readily today thanks to increasing awareness of the syndrome and … [Read more...]
Dry Eye Clinics Add Value to Your Practice
March 29, 2012 By Leave a Comment
A dry eye clinic can be a very important part of a comprehensive ophthalmology practice. By Sheldon Herzig, MD, FRCSC Dry eye syndrome (DES) has increasingly become a major concern, particularly as eye care specialists face growing numbers of cases arising from iatrogenic causes like PRK and LASIK. It has … [Read more...]
Symptom-based approaches do not seem appropriate for MGD estimation
March 28, 2012 By Leave a Comment
Asymptomatic MGD is more common than Symptomatic according to an article soon to be published in IOVS. In fact asymptomatic patients were more than two times more prevalent than those with symptoms. This publication is significant as it demonstrates if clinicians rely only symptoms of meibomian gland disfunction before evaluating … [Read more...]
